Estée Lauder: Premium Beauty Brand Equity Restoration Study

Hunting ten-year five-baggers among great growth stocks — pressing the upside question: "Can it get much bigger?"

• QHow high is its market ceiling? Is it growing an existing pie, or creating an entirely new market?5/10

  A

  The ceiling is large enough, but EL is mainly "growing and defending an existing pie" rather than creating an entirely new market — and that's the first soft reading when measuring it against Baillie Gifford's LTGG yardstick.

  The category itself isn't small. McKinsey describes global beauty as a market of about $446 billion in 2023, projected to reach about $590 billion by 2030 (spanning the four core categories of makeup, skincare, fragrance, and hair care), implying roughly a 4% compound growth rate. Fragrance is the structural bright spot within it — McKinsey judges it will still post about an 8% CAGR through 2030, with price growth outpacing volume growth. The U.S. prestige channel isn't broken either: the report cites Circana data showing U.S. prestige beauty sales grew 4% year-over-year to $36 billion in 2025, with the prestige channel growing another 6% year-over-year in Q1 2026.

  But "a big category" and "this company creating new demand" are two different things. EL's role is to use its brand matrix — Estée Lauder, La Mer, Clinique, M·A·C, Jo Malone London, Le Labo, TOM FORD, The Ordinary, and others — to compete for share within a premium beauty pie that has existed for decades; it isn't a platform pioneering an entirely new consumption format, but rather an incumbent player competing for mindshare and channel presence within a mature category. The report's own conclusion points the same way: EL today is "more like a company under repair in a good industry, not yet the best company in a good industry."

  For a framework like Baillie Gifford's, which hunts for "five times in ten years," what matters isn't the absolute size of the TAM, but whether "this company can sustainably grow its own share faster than the market." This is exactly where EL draws the most doubt: the report discloses that its revenue peaked at $17.737 billion in FY2022, then slid all the way down to $14.326 billion in FY2025 — in a still-growing industry, it has been losing share over the past several years, not expanding it.

  So my judgment is: the ceiling isn't the constraint (the industry is large enough, and categories like fragrance still have structural upside), but EL is neither creating a new market nor has it reliably grown its existing pie in recent years. Its appeal comes from the elasticity of "catching back up with the industry after repair," rather than the imaginative upside of "defining and dominating a new category" — this is the most fundamental gap between it and a typical LTGG holding.

  Jun 10, 2026
• QCan its revenue at least double over the next five years? Is growth driven mainly by volume, price, or new business lines?3/10

  A

  Nearly certain: EL's revenue will not double over the next five years — and the driver is more about price and mix than a volume surge, which is the hard constraint keeping it below Baillie Gifford's "five-year revenue doubling" bar.

  Start with the baseline and the official roadmap. On the report's figures, EL's FY2025 net sales were $14.326 billion, versus $15.608 billion in FY2024 — a continued decline. The company's own forward guidance isn't a doubling story; it's a recovery story: management has set FY2026 organic sales growth guidance at +1% to +3%, and the preliminary FY2027 target is only 3% to 5% organic net sales growth. Linearly extrapolating single-digit growth over five years puts revenue at roughly $16.5–17.5 billion — an order of magnitude short of "doubling to $28 billion+" — unless a large acquisition happens, but the report specifically lists "doing another large deal" as a major risk, not an upside.

  Now look at the growth mix — this is where EL diverges most from a typical LTGG holding: its incremental growth clearly leans toward "price + mix" rather than "volume." The report discloses that fragrance and most categories already showed a clear price/mix contribution in FY2024, and skincare, fragrance, and hair care all showed price contributions in the first nine months of FY2026 too; fragrance organic growth ran about +10% in H1 FY2026, the strongest engine of the period. But price-driven growth has a ceiling — the report also notes EL "has pricing power, but not costless pricing power": it can only raise prices comfortably when brand heat, innovation success, and channel health line up, and once destocking hits or vitality weakens, price increases stop being painless.

  One genuine, worth-noting inflection point: in Q3 FY2026 EL posted its first positive organic sales growth in four years, with quarterly net sales of $3.712 billion, up 5% year-over-year, with both volume and price recovering somewhat. This shows the answer to "can revenue grow again" is shifting from "uncertain" to "yes."

  But "growing again" and "doubling in five years" are two different orders of magnitude. Honestly: EL's realistic path is single-digit organic recovery, driven jointly by price, mix, and a modest return of volume; doubling in five years is neither in management's targets nor in any reasonable scenario. By Baillie Gifford's yardstick, EL clearly fails this question.

  Jun 10, 2026
• QFive years out, what takes over as the next growth engine? Does this "second curve" exist today?3/10

  A

  Frankly: EL doesn't have a clear, independent "second curve" today. Its story is essentially about repairing the main curve — getting the existing brand matrix growing again and margins back to double digits — rather than incubating a new growth pole that can take over. Viewed through a Baillie Gifford lens, this is one of its most damaging shortfalls.

  First, rule out a few things easily mistaken for a "second curve." One, fragrance. Fragrance posted organic double-digit growth in the first nine months of FY2026, the strongest engine of the period, but it's a core category EL has run for decades — the fastest-recovering piece of the main curve, not a new growth pole. Two, TOM FORD licensing income. The report discloses that after acquiring the TOM FORD brand in FY2023, the company licensed the trademark to Marcolin and Zegna for eyewear and fashion, creating a new licensing revenue stream — a genuinely new revenue form, but small in scale, and the same brand grouping already booked a combined $308 million in makeup-related impairments (including TOM FORD and Too Faced) in FY2025 — nowhere near enough to carry the weight of "taking over." Three, the China and travel retail recovery. That's cyclical healing, not a structural new curve.

  So what are the real second-curve candidates? The two most plausible: one is younger, efficacy- and value-oriented brands like The Ordinary and Dr.Jart+ extending beyond the premium lineup; the other is customer-base resets driven by new channels like Amazon Premium Beauty and TikTok-ification. But the report puts these squarely on the risk side instead — "brand heat continuing to migrate toward L'Oréal, K-beauty, emerging brands, and owned-channel traffic" is listed as a bear-case reason, which shows these new trends are, for now, more a disruptive pressure on EL than a new engine it leads.

  Against the Baillie Gifford yardstick: LTGG favors companies that, beyond the core business, already have a faintly visible curve today that could re-create the company down the road. EL can't offer this. All of its forward guidance is riding on "repairing the main curve" — management's FY2027 target is 3–5% organic growth plus a 12.5%–13.0% adjusted operating margin, all recovery metrics, with none of them a genuine "zero-to-one" new business.

  Conclusion: a second curve is essentially absent today (or too weak to be part of the investment logic). EL's upside depends entirely on the main business's repair succeeding, and it lacks the kind of "regenerative growth optionality" Baillie Gifford values most. On this question, it's clearly weak.

  Jun 10, 2026
• QWhat is its core competitive advantage? Will this moat widen or narrow over the next three to five years?5/10

  A

  EL's core competitive advantage is "a global premium beauty brand matrix plus a channel network built up over decades," but this moat has clearly narrowed over the past few years; where it goes over the next three to five years depends on whether the transformation succeeds — the base case is "stabilize first, with re-widening still to be proven," not a certain widening.

  The true substance of the moat is brand power. The report judges brand advantage as the only dimension where EL is rated "Yes" and still relatively strong — La Mer, Clinique, Estée Lauder, Jo Malone London, Le Labo, M·A·C, and others remain globally recognized premium brands, and the company can still drive category growth through its brands and lift gross margin through pricing and mix optimization (gross margin returned to 76.4% in Q3 FY2026, showing the brands haven't lost their pull). But the report also honestly breaks out the moat's other dimensions: network effects are "essentially none," switching costs are "low-to-moderate" (skincare and fragrance see habitual repeat purchase, but switching in makeup and hair care isn't hard), capital allocation capability is "middling-to-weak," and operating capability is "once strong, now under repair." This isn't a moat that leads on every dimension.

  "Narrowing" is backed by hard evidence, not just opinion. The report's logic is sharp: if the moat were continuously widening, the company shouldn't have gone through such a prolonged revenue and profit pullback from FY2022 to FY2025 — revenue sliding from $17.737 billion in FY2022 to $14.326 billion in FY2025 is itself evidence of the moat eroding. The sources of erosion are specific: creator content, TikTok-ification, Amazon Premium Beauty, and the rise of Sephora and multi-brand retail make it easier for new brands to cold-start, and consumers are more willing to switch between price points and channels.

  The comparison with the strongest rival makes it clearer. The report discloses that L'Oréal posted €44.05 billion in sales in 2025, with a 20.2% operating margin and e-commerce over 30% of sales — its moat is leadership in brand, innovation, channel, and organizational efficiency all at once, while EL now has "only the first two still relatively strong, with the latter two under repair." This is the gap of "close on brand quality, but significantly behind on organizational efficiency and execution."

  Where does it go over the next three to five years? This is a genuine fork, and I won't pretend to certainty: the path to widening requires PRGP and Beauty Reimagined to repair organizational efficiency and channel health — the company has already fully established the One ELC operating model and expanded the restructuring target to 9,000–10,000 net job cuts, and adjusted operating margin expanded to 15% in Q3 FY2026 alone, which is genuine delivery; the risk of continued narrowing is China, travel retail, and North American multi-brand channels continuing to lose share.

  Conclusion: the core advantage is real (the brand matrix), but this is a moat that's "still wide, but no longer stable enough." The base-case judgment is stabilization first over the next three to five years, with re-widening yet to be seen — widening isn't the default outcome, it has to be earned through execution. For the "moat with certain widening" that Baillie Gifford wants, EL remains an unproven proposition and can't score high.

  Jun 10, 2026
• QIf its core business were disrupted, does it have the genes to reinvent itself? How does it handle mistakes and bad news?4/10

  A

  EL's attitude toward mistakes and bad news is a plus — disclosure is candid and its self-rescue moves are decisive; but on "the genes to reinvent itself if the core business were disrupted," what it offers looks more like "efficiency restructuring of the same business" than "the regenerative ability to disrupt itself." On this question EL sits in the middle: plenty of honesty, but insufficient evidence of disruptive self-renewal.

  Start with "how it handles mistakes and bad news," where EL genuinely does well. The report notes management doesn't shy away from disclosing problems: it has repeatedly flagged risks over recent quarters — China, travel retail, the Middle East conflict, tariffs and inflation, organizational restructuring; the preliminary FY2027 outlook in Q3 FY2026 even spelled out explicit assumptions (the Middle East conflict doesn't disrupt operations, the geopolitical and tariff environment doesn't worsen, consumer sentiment doesn't weaken further), acknowledging the turnaround isn't linear. More impressively, it doesn't hide its own capital-allocation mistakes — in FY2025 it booked a combined $308 million in makeup-related impairments for TOM FORD, Too Faced, and others, and recorded $1.286 billion in goodwill and other intangible asset impairments for the full year, effectively admitting publicly that it overpaid in the past. This kind of owning up is a mark of healthy governance.

  Now look at execution on self-rescue, which is indeed decisive. Facing four years of decline, the company rolled out PRGP (Profit Recovery and Growth Plan) and Beauty Reimagined, fully established the One ELC operating model, and expanded the net job-cut target from 5,800–7,000 to 9,000–10,000, with adjusted operating margin already expanding to 15% in Q3 FY2026 alone. This isn't just talk — it's real cuts.

  But "the genes to reinvent itself" asks a tougher question: if its core playbook — selling through department stores, airport duty-free, premium boutiques, and traditional prestige mindshare — were completely rewritten, could it grow into an entirely new version of itself? The evidence here is thin. The report's strongest bear case is precisely that EL is "a premium beauty company being redefined by the market" — historically it fed off old channels and old mindshare, while in the new world consumers are more fragmented, channels are decentralizing, and new brands rise more easily, and not every brand in EL's portfolio still has enough cultural momentum and product-innovation speed. In other words, what it's doing now is repairing the old engine and running it more efficiently, rather than proving it can be reborn as a different species after disruption.

  Against the Baillie Gifford yardstick: LTGG favors companies that have proven, in a near-death moment, that they can "disrupt themselves." EL has no such recent example — every one of its moves sits on the extension line of "repairing the core business, raising efficiency, cutting cost." Its governance is honest and its execution is decisive (which puts it ahead of many companies that hide from their problems), but it lacks proven, disruptive regenerative genes.

  Conclusion: handling mistakes and bad news — pass, and a plus; genes for self-reinvention — questionable. Taken together, EL sits in the middle on this question: a good student willing to own its mistakes and take action, but not yet proven to be the kind of species that can be reborn from disruption.

  Jun 10, 2026
• QDoes management (especially the founder) have a long-term view, and are their interests deeply aligned with the company? Are they willing to sacrifice current profit for a payoff five to ten years out?5/10

  A

  Management is a mix of "long-term view present, family control ensuring long-termism, but interest alignment and the execution track record are weak" — this is exactly the area where the report is most guarded on EL. Baillie Gifford places great weight on "founder/management being deeply bound to the company's fate and willing to sacrifice the present for ten years out"; EL passes on "willing to sacrifice the present" but clearly falls short on "deep interest alignment."

  Start with the long-term view and "willingness to sacrifice current profit for five to ten years out" — EL passes here, even shines. Family control itself provides an institutional foundation for long-termism: the report discloses the company is a controlled company under NYSE rules, with Class A shares carrying 1 vote each, Class B shares carrying 10 votes each and held only by the Lauder family and related entities, with the family holding ultimate control through more than 50% of voting power (per the report's proxy-statement citation, no specific page attached). The benefit of family control is not having to please short-term capital for the sake of quarterly numbers. More concrete evidence is that it's genuinely sacrificing the present for the long term: per the report, cumulative declared dividends through the first nine months of FY2026 fell to $1.05 per share (versus $2.64 for full-year FY2024), with the quarterly dividend down to $0.35, prioritizing cash for balance-sheet repair and the transformation; it's also pushing forward PRGP, expanding the net job-cut target to 9,000–10,000 — all moves that sacrifice the short term for long-term efficiency.

  But on Baillie Gifford's core question of "deep alignment of interests with the company," EL doesn't answer well. New CEO Stéphane de La Faverie has served since January 2025, with a long tenure at both L'Oréal's luxury division and the company itself, and his direction is credible; but per the report's citation of the company's 2025 proxy statement, his direct personal shareholding is small — only 11,125 Class A shares plus 46,336 options, with an FY2026 compensation framework of $1.5 million base salary + $3 million target bonus + $10 million target equity awards. In other words, his alignment with minority shareholders comes more from equity awards he has yet to earn than from a large, historically accumulated ownership stake. The report's phrasing is restrained but on point: this "shouldn't be romanticized as the CEO being completely in the same boat as minority shareholders."

  The heavier deduction is in the capital-allocation track record. The report rates this dimension "middling-to-weak" with hard evidence: it acquired the TOM FORD assets for a total cost of $2.578 billion in FY2023, then booked an impairment two years later; buybacks were even worse — "aggressive when expensive, powerless when cheap" — large annual buybacks in FY2019–FY2022 (peaking at about $2.309 billion in FY2022) happened when the stock was far above today's level, and once the price fell, only about $35 million each remained in FY2024 and FY2025. This is textbook reverse capital allocation, and it directly undermines confidence in management's ability to "spend shareholders' money wisely."

  Against the Baillie Gifford yardstick: it wants all three of "founder-level long-term view + deep alignment with the company's fate + rational capital allocation" present together. EL has the first (family control plus willingness to sacrifice the present), lacks the second (thin CEO ownership, alignment resting on future awards), and has a clear blemish on the third (M&A impairments plus reverse buybacks).

  Conclusion: the direction deserves time, but the alignment and the historical record don't deserve a high score. This is a management team "worth continuing to watch, but not yet worth trusting blindly" — by the Baillie Gifford yardstick, it qualifies on "willing to sacrifice the present for the long term" but is weak on "deep interest alignment and capital allocation."

  Jun 10, 2026
• QIf it disappeared tomorrow, how much would customers miss it? Is its growth model sustainable, without relying on harming society or skirting regulation?5/10

  A

  If EL disappeared tomorrow, consumers would miss a handful of specific brands (La Mer, Jo Malone London, Le Labo, and others), but they wouldn't miss "the company EL" — premium beauty has plenty of substitute supply, and EL doesn't rise to "indispensable." On the other hand, its growth model is clean, sustainable, and doesn't rely on harming society or crossing regulatory lines, which is a genuine plus. Weighing the two, EL is weak on this question but has a bright spot.

  Start with "how much would customers miss it" — this needs to be broken down to the brand level, not the company level. The report judges brand power to be EL's true core moat; products like La Mer cream do have habitual repeat purchase, with emotional and identity attachment, and some loyal users would genuinely feel a loss without them. But the report also rates switching costs as "low-to-moderate": skincare and fragrance see habitual repeat purchase, but switching in makeup and hair care isn't hard, and consumers are increasingly willing to switch between price points and channels. More importantly, "missing a specific brand" isn't the same as "indispensable" — if EL disappeared, substitutes for La Mer, similarly priced fragrances to Jo Malone's, and alternative makeup supply to M·A·C's would be on the shelf immediately; L'Oréal, K-beauty, e.l.f., and emerging DTC brands are all competing for the same wallets. The report's bear case is blunt about this: in the new world of decentralized channels and easily-rising new brands, EL's irreplaceability is being diluted. So the answer is: miss individual brands — yes; miss the company itself, with no substitute to be found — no.

  A side-by-side comparison makes the level of indispensability clearer. Against the report's data, L'Oréal posted €44.05 billion in sales in 2025, a 20.2% operating margin, and e-commerce over 30% of sales — it has denser innovation and channel presence and stronger customer stickiness; EL's revenue, meanwhile, slid from $17.737 billion in FY2022 all the way down to $14.326 billion in FY2025 — the market has voted with its feet, proving that when EL loses share, demand is smoothly absorbed by others, which is itself hard evidence of being "replaceable."

  But on "whether the growth model is sustainable without relying on harming society or regulation," EL answers cleanly, and this deserves clear credit. Its revenue is essentially selling skincare, makeup, fragrance, and hair-care products (with a small layer of TOM FORD trademark licensing income), not financial engineering, not subsidy-driven growth, not ad-traffic monetization, and not reliant on regulatory arbitrage or data misuse — the report specifically stresses that the "hard to understand" component of its business model is minimal. It has none of the regulatory overhang a prescription drug faces, nor the antitrust/privacy systemic risk a platform company faces. What it deals with are external cyclical variables like tariffs, geopolitics, and consumer sentiment, not "the growth model itself crossing a social line." This means its growth is sustainable on the ethics and regulatory dimension, with no hidden risk of "earning money it shouldn't."

  Against the Baillie Gifford yardstick: LTGG wants both "indispensable enough that the whole world would miss it if it vanished" and "growth that's clean, socially and regulatorily tolerable over the long run." EL clearly falls short on the former (highly replaceable, belonging to the "miss the brand but not short on supply" category) and fully passes the latter (clean business, no regulatory red flags).

  Conclusion: indispensability — weak; social and regulatory sustainability — pass, and a plus. Taken together, EL sits on the weak side of this question: it's a company people like and one that earns cleanly, but it's far from the kind the world can't do without.

  Jun 10, 2026
• QHow are this business's unit economics (gross margin, incremental returns)? Does it get better or worse as it scales? Where does the money it earns go?5/10

  A

  The "quality" of the unit economics is good — gross margin runs around 75%, typical of a premium consumer product; but "incremental returns" have been poor in recent years, with profit collapsing faster than revenue as scale shrinks, and the money earned hasn't historically been spent well. Overall, EL is "good unit economics + impaired operating leverage + middling capital allocation" — a mixed picture on this question.

  Start with the quality of gross margin and unit economics — this is EL's genuine strength. The report discloses 75.5% gross margin for the first nine months of FY2026, back up to 76.4% in Q3 FY2026 alone; full-year FY2025 gross margin also expanded to 74.0%. The product margin on a jar of La Mer or a bottle of fragrance is extremely high — a direct reflection of brand premium. The ceiling on unit economics is impressive.

  But "does it get better or worse as it scales" depends on operating leverage, and EL has been a cautionary tale on this front in recent years. The report identifies its cost structure as "high gross margin, heavy brand and channel investment": gross profit was $8.625 billion in the first nine months of FY2026, but SG&A ran as high as $7.202 billion, plus $520 million in restructuring charges, so operating leverage is extremely sensitive to scale. The result is margin declining far faster than revenue — revenue slid from $17.737 billion in FY2022 to $14.326 billion in FY2025 (about -19%), but operating profit fell straight from $3.170 billion in FY2022 to -$785 million in FY2025, with adjusted operating margin sliding from its peak to 8.0% in FY2025. This shows its incremental returns cut both ways: profit can recover quickly when revenue recovers (adjusted operating margin already expanded to 15% in Q3 FY2026 alone), but profit collapses quickly when volume comes under pressure. This kind of high fixed/semi-fixed cost structure keeps it short of the compounding trait Baillie Gifford favors — "the bigger it gets, the higher and more stable the incremental returns" — the report's checklist directly marks "is capital returns excellent" as a fail.

  Now look at "where the money earned goes," the most questioned piece. The report rates capital allocation "middling-to-weak" with solid evidence: it acquired the TOM FORD assets for a total cost of $2.578 billion in FY2023, then booked an impairment within two years; full-year FY2025 recorded $1.286 billion in goodwill and intangible asset impairments; buybacks were even worse — "aggressive when expensive, powerless when cheap" (large buybacks at high prices in FY2019–FY2022, dwindling to a fraction once the stock fell). In other words, a meaningful share of the cash generated by high gross margins has, in the past, been consumed by low-quality M&A and reverse buybacks.

  That said, the cash-generating ability itself is healthy, and this deserves fair credit. The report discloses that even with a reported net loss of $1.133 billion in FY2025, operating cash flow was still $1.272 billion, rising back to $1.197 billion in the first nine months of FY2026 — this is a business where "profit can collapse, but cash doesn't necessarily vanish right away." The company is now also prioritizing cash for balance-sheet repair (dividend cuts, terminating the Puig merger talks to reduce the risk of further mistakes), and capital-allocation discipline is improving.

  Against the Baillie Gifford yardstick: it wants "high, sustainable incremental returns plus reinvesting cash into high-return opportunities to compound." EL's gross-margin quality qualifies, but its operating leverage is impaired, ROIC isn't excellent, and its historical reinvestment returns are poor — it looks more like "good product economics dragged down by mediocre corporate economics."

  Conclusion: unit economics (gross margin/product level) — excellent; incremental returns and scale effects — impaired (high SG&A leverage, extremely fragile when profit swings downward); where the money goes — historically off-target, now being corrected. Taken together, EL sits on the weaker-of-middling side of this question: the foundation of a good business is there, but it hasn't yet been converted into the high-quality compounding Baillie Gifford wants.

  Jun 10, 2026
• QWhat conditions would all need to hold for it to rise five-fold in ten years? Are these conditions realistic? What expectations does today's share price already imply?2/10

  A

  A five-fold rise in ten years is already a stretch for EL, let alone ten-fold — its realistic path is a margin recovery riding on single-digit organic growth, lacking the dual engine of revenue and valuation re-rating that a five-fold/ten-fold move requires; and today's roughly $86–87 share price already implies the optimistic expectation that "the transformation has basically succeeded," leaving almost no discount left for the recovery.

  First, lay out clearly what conditions would need to hold simultaneously for a five-fold rise in ten years (the hard math under the Baillie Gifford yardstick). Starting from the report's FY2025 net sales of $14.326 billion, a five-fold rise in ten years would roughly require all of the following at once: (1) revenue growing at a rate far above single digits for a full decade (at least more than doubling); (2) adjusted operating margin not just recovering from FY2025's 8.0% but climbing further to, and holding at, the high teens (approaching L'Oréal's 20%+); (3) the market being willing to award a high valuation multiple reflecting "being seen as a top student again"; (4) China, travel retail, and North American multi-brand channels all turning into tailwinds with no repeated destocking; (5) management's capital allocation flipping from "value destruction" to "value creation." None of these five conditions is easy on its own, and having all of them hold simultaneously for a decade without being derailed by a single cycle or M&A misstep has a very low real-world probability.

  And management's own roadmap is squarely at the "recovery" scale, not the "five-fold" scale. Its preliminary FY2027 target is 3–5% organic growth plus a 12.5%–13.0% adjusted operating margin, with FY2026 adjusted operating margin guidance at 9.8%–10.2% — this pulls the margin back to around thirteen points and revenue back to single-digit growth, which doesn't even reach "doubling in five years," let alone the revenue/profit compounding speed needed to support "five-fold in ten years." The report's three-tier owner earnings discount model points to the same conclusion: conservative at about $40/share, neutral at about $63/share, optimistic at about $91/share — even the optimistic scenario implies only a "reasonable" ten-year return, not "five-fold."

  Now the most critical part: "what expectations does today's share price already imply." Updated to the current period: EL trades at about $86.56 with a market cap of about $31.3 billion (as of June 9, 2026; it was $91.20 / about a $33.3 billion market cap when the report was drafted, and has since pulled back on Q3-earnings volatility). It's still loss-making on a GAAP basis with TTM net income of about -$248 million, so the current P/E doesn't apply, but the forward P/E is about 28.7x — a multiple that "already believes profit will be repaired." Against the report's figures, using an FY2025 reported free cash flow of about $670 million, the free cash flow yield is only about 2%, clearly below the current U.S. 10-year Treasury yield of about 4.48% (per the report). In other words, what today's price implies is: the FY2027 margin target gets delivered, organic growth stays positive, and China and travel retail don't blow up again — the market has already advanced "Beauty Reimagined largely succeeding" into the share price.

  Worth noting: the inflection signal has genuinely gotten more concrete. Q3 FY2026 adjusted EPS was $0.91, well above the $0.59 estimate, the company posted its first positive organic sales growth in four years and raised full-year guidance, and sell-side consensus is also "buy," with an average target price of about $95.43. But this actually reinforces the judgment that "the optimism is already priced in": the current price is only about 10% below the sell-side target — those are the odds of a "recovery-type return," not a "five-fold/ten-fold" return.

  Against the Baillie Gifford yardstick: it wants a holding where "just a few conditions need to hold to support a five-fold move, and the current price hasn't already advanced the good outcome." EL is the opposite — it needs a long list of conditions to hold simultaneously just to scrape together a "reasonable return," and the share price is already sitting near the optimistic scenario.

  Conclusion: five-fold/ten-fold in ten years — unrealistic (lacking the dual engine of revenue and re-rating, with management's targets only reaching "recovery" scale); what today's price implies — already the optimistic expectation that "the transformation has basically succeeded," with an insufficient margin of safety. By the Baillie Gifford yardstick, EL is clearly weak on this question.

  Jun 10, 2026
• QWhy hasn't the market recognized all this yet? Does it not understand, not respect, or not look far enough ahead? What would become the "narrative inflection point"?3/10

  A

  The key conclusion first: in EL's case, the Baillie Gifford-style question of "why hasn't the market recognized this" actually has it backwards — the market recognized it long ago, and has even priced in transformation success in advance. It isn't a good company obscured by the market "not understanding / not respecting / not looking far enough" — it's much closer to "fully recognized, with optimism already priced in." So EL is weak on this question: it lacks the kind of space Baillie Gifford values most, where "the market is wildly wrong and hands you a cognitive-gap dividend."

  Start with "does it not understand, not respect, or not look far enough" — none of the three really holds. Not understand? No — this is a business the report explicitly judges "understandable," selling products (skincare, makeup, fragrance, hair care, plus a small licensing layer), with dense institutional coverage and a clear sell-side consensus. Not respect? Not really either — the market is taking its recovery seriously: the stock jumped after Q3 FY2026 earnings beat, sell-side firms raised their targets, consensus remains "buy," with an average target price of about $95.43. Not look far enough? The market actually looks quite far ahead — the forward P/E of about 28.7x it's assigning is precisely paying for "margins recovering to the teens a few years out," not just staring at today's losses.

  So what is the market's real read? It has already advanced the good outcome into the price. Updated to the current period: EL trades at about $86.56, with a market cap of about $31.3 billion (as of June 9, 2026). The report's three-tier intrinsic value (conservative about $40, neutral about $63, optimistic about $91 per share) shows the current price is already close to the optimistic scenario; it's also only about 10% below the sell-side average target. This isn't "undervalued, waiting to be discovered" — it's "the recovery narrative has already been accepted by the market, and the odds have been flattened." The report's own judgment aligns with this: buying it is "more like betting, after the market has already come back around to believing in the turnaround, that it can keep delivering from here," rather than picking it up cheap during pessimism.

  So "what would become the narrative inflection point"? This is the only genuinely informative part of this question, and the inflection could go in either direction. Upward (further re-rating) inflection points: (1) FY2027 genuinely pushes adjusted operating margin to the 12.5%–13.0% target's upper end or beyond, proving "recovery" is actually "acceleration"; (2) mainland China and global travel retail shift from "no longer worsening" to "a sustained tailwind"; (3) a second volume-carrying growth engine emerges beyond fragrance. Downward (narrative breaking) inflection points (which the report lists as reassessment signals): (1) FY2027 margin clearly falls short of the target; (2) China and travel retail turn weak again; (3) major brands lose share for several consecutive periods; (4) another large goodwill/intangible impairment shows up; (5) management restarts a large acquisition; (6) cash-flow improvement turns out to be driven mainly by a one-time working-capital release rather than genuine operating quality. Because the current price already has optimism baked in, a downward inflection point's damage to the share price is likely greater than the extra return from an upward one — the classic asymmetry of a name where "optimism is already priced in."

  Against the Baillie Gifford yardstick: LTGG loves the situation where "the market has punished a name unfairly because it doesn't understand or doesn't look far enough, leaving you a cognitive gap." EL is the opposite — full recognition, optimism priced in, odds flattened. Its real variable isn't "when will the market wake up," but "whether the company can deliver the already-priced-in optimism on schedule"; any shortfall in delivery is more likely to become a downward narrative inflection point.

  Conclusion: the market hasn't "yet to recognize" this — it has already recognized it and priced it in ahead of time; EL doesn't belong to the "obscured cheap good company" category, and it lacks the cognitive-gap dividend Baillie Gifford wants. By the Baillie Gifford yardstick, EL is clearly weak on this question — its story is more about "delivery risk" than "undiscovered upside."

  Jun 10, 2026